+143.3%
MRNA vs VSH
+95.1%
+48.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | VSH | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | +0.7% | -4.1% | -3.3% |
| 7D | -10.1% | +3.5% | -13.6% | -9.6% |
| 30D | +126.7% | -4.4% | +131.1% | +125.6% |
| 3M | +184.1% | -45.8% | +229.9% | +189.8% |
| 6M | +143.3% | +90.1% | +53.1% | +61.5% |
| All | +143.3% | +95.1% | +48.1% | +61.5% |
Cumulative growth
Daily Returns
Daily percentage return beside VSH.
Daily Out/Under-Performance
Portfolio return minus VSH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VSH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded VSH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling